- Home
- CLLS vs EVM Comparison
CLLS vs EVM Comparison
Compare CLLS & EVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLLS
- EVM
- Stock Information
- Founded
- CLLS 1999
- EVM 2002
- Country
- CLLS France
- EVM United States
- Employees
- CLLS N/A
- EVM N/A
- Industry
- CLLS Biotechnology: Pharmaceutical Preparations
- EVM Finance/Investors Services
- Sector
- CLLS Health Care
- EVM Finance
- Exchange
- CLLS Nasdaq
- EVM Nasdaq
- Market Cap
- CLLS 240.2M
- EVM 233.7M
- IPO Year
- CLLS 2007
- EVM N/A
- Fundamental
- Price
- CLLS $1.89
- EVM $9.45
- Analyst Decision
- CLLS Buy
- EVM
- Analyst Count
- CLLS 2
- EVM 0
- Target Price
- CLLS $8.00
- EVM N/A
- AVG Volume (30 Days)
- CLLS 22.9K
- EVM 55.8K
- Earning Date
- CLLS 11-04-2024
- EVM 01-01-0001
- Dividend Yield
- CLLS N/A
- EVM 4.01%
- EPS Growth
- CLLS N/A
- EVM N/A
- EPS
- CLLS N/A
- EVM 0.20
- Revenue
- CLLS $19,635,000.00
- EVM N/A
- Revenue This Year
- CLLS $271.02
- EVM N/A
- Revenue Next Year
- CLLS $33.48
- EVM N/A
- P/E Ratio
- CLLS N/A
- EVM $47.61
- Revenue Growth
- CLLS N/A
- EVM N/A
- 52 Week Low
- CLLS $0.96
- EVM $7.67
- 52 Week High
- CLLS $3.77
- EVM $9.59
- Technical
- Relative Strength Index (RSI)
- CLLS 34.47
- EVM 33.70
- Support Level
- CLLS $1.95
- EVM $9.43
- Resistance Level
- CLLS $2.06
- EVM $9.56
- Average True Range (ATR)
- CLLS 0.10
- EVM 0.08
- MACD
- CLLS -0.01
- EVM -0.02
- Stochastic Oscillator
- CLLS 2.70
- EVM 6.25
About CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC, product candidates in other therapeutic indications.
About EVM Eaton Vance California Municipal Bond Fund of Beneficial Interest $.01 par value
Eaton Vance California Municipal Bond Fund is an investment company with an objective to provide current income exempt from regular federal income tax, including alternative minimum tax, and, in state specific funds, taxes in its specified state. The company provides its solutions to individual investors, institutional investors, high net worth individuals, family office investors, and financial professionals. It offers a range of equity, income and alternative strategies to institutional investors, both in the United States and internationally.